{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:46:45Z","timestamp":1747162005951,"version":"3.40.5"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ijcard.2015.05.128","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T16:28:34Z","timestamp":1432225714000},"page":"1-2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Eplerenone's role in the management of complex cardiovascular disorders"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2771-4260","authenticated-orcid":false,"given":"Andrew J.","family":"Stewart Coats","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Shewan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.05.128_bb0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2015.05.128_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2013.06.046","article-title":"Cross-talk between mineralocorticoid receptor\/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes","volume":"169","author":"Tsai","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2015.05.128_bb0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2011.06.100","article-title":"Aldosterone induces electrical remodeling independent of hypertension","volume":"164","author":"Dartsch","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2015.05.128_bb0020","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1016\/j.ijcard.2013.07.163","article-title":"Eplerenone in systemic right ventricle: double blind randomized clinical trial. The evedes study","volume":"168","author":"Dos","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2015.05.128_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijcard.2013.08.102","article-title":"A cornerstone of heart failure treatment is not effective in experimental right ventricular failure","volume":"169","author":"Borgdorff","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.128_bb0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.17987\/icfj.v1i3.33","article-title":"The Management of Heart Failure with Preserved Ejection Fraction (HFpEF)","volume":"1","author":"Stewart Coats","year":"2014","journal-title":"Int. Cardiovasc. Forum J."},{"key":"10.1016\/j.ijcard.2015.05.128_bb0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2014.02.018","article-title":"IN HF Outcome Investigators. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry","volume":"173","author":"Senni","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"15","key":"10.1016\/j.ijcard.2015.05.128_bb0040","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"TOPCAT Investigators. Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2015.05.128_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijcard.2014.09.091","article-title":"Efficacy and safety of eplerenone in the management of mild to moderate arterial hypertension: systematic review and meta-analysis","volume":"177","author":"Pelliccia","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.128_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2014.10.150","article-title":"Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension","volume":"200","author":"Pelliccia","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2015.05.128_bb0055","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/j.ijcard.2013.12.154","article-title":"Effects of eplerenone on P-wave signal-averaged electrocardiogram in hypertensive patients with coronary artery disease","volume":"172","author":"Kurisu","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2015.05.128_bb5100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijcard.2013.11.001","article-title":"A statement onethical standards in publishing scientific articles in the International Journal of Cardiology family of journals","volume":"170","author":"Shewan","year":"2014","journal-title":"Int. J. Cardiol.","ISSN":"https:\/\/id.crossref.org\/issn\/0167-5273","issn-type":"print"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315011912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315011912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T07:23:31Z","timestamp":1566717811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315011912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":12,"alternative-id":["S0167527315011912"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.05.128","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eplerenone's role in the management of complex cardiovascular disorders","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.05.128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}